Skip to main content
Livermore
Livermore
ZHEN

Euclidean Capital LLC

SEC CIK
0001825034
Latest filing
Aug 14, 2026

RAPT holding history

RAPT Therapeutics, Inc. in every 13F filed by Euclidean Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RAPT overviewAll 13F holders of RAPTFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of RAPT by Euclidean Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−82,234−100.0%Sold outHolders
Q4 202582,234$2.79M0.8%00.0%UnchangedHolders
Q3 202582,234$2.12M0.9%00.0%UnchangedHolders
Q2 202582,234$657.9K0.2%−575,665−87.5%ReducedHolders
Q1 2025657,899$802.6K0.3%00.0%UnchangedHolders
Q4 2024657,899$1.04M0.1%00.0%UnchangedHolders
Q3 2024657,899$1.32M0.1%00.0%UnchangedHolders
Q2 2024657,899$2.01M0.3%00.0%UnchangedHolders
Q1 2024657,899$5.91M0.8%00.0%UnchangedHolders
Q4 2023657,899$16.3M1.8%00.0%UnchangedHolders
Q3 2023657,899$10.9M2.4%+86,666+15.2%AddedHolders
Q2 2023571,233$10.7M2.7%+138,333+32.0%AddedHolders
Q1 2023432,900$7.94M7.0%00.0%UnchangedHolders
Q4 2022432,900$8.57M8.0%00.0%UnchangedHolders
Q3 2022432,900$10.4M9.7%00.0%UnchangedHolders
Q2 2022432,900$7.90M6.7%00.0%UnchangedHolders
Q1 2022432,900$9.52M5.5%00.0%UnchangedHolders
Q4 2021432,900$15.9M9.0%−202,277−31.8%ReducedHolders
Q3 2021635,177$19.7M9.6%−100,624−13.7%ReducedHolders
Q2 2021735,801$23.4M7.6%00.0%UnchangedHolders
Q1 2021735,801$16.3M5.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.